AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 10th, 2003 • Amgen Inc • Biological products, (no disgnostic substances) • Washington
AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”), dated as of the Effective Date (as defined below), as amended and restated as of January 2, 2003, between Amgen Inc., a Delaware corporation (the “Company”), and Edward V. Fritzky (the “Executive”). This Agreement amends and restates in its entirety the Employment Agreement, dated as of the Effective Date, between the Company and the Executive (the “Original Agreement”). References herein to this “Agreement” shall refer to the Original Agreement, as hereby amended and restated;
AMENDMENT NO. 3 TO THE ENBREL® SUPPLY AGREEMENTAmgen Inc • March 10th, 2003 • Biological products, (no disgnostic substances)
This Amendment No. 3 (this “Amendment No. 3”) is made as of this 18th day of December, 2002 (the “Amendment No. 3 Effective Date”) by and among Immunex Corporation, a Washington corporation having its principal place of business at One Amgen Center Drive, Thousand Oaks, California 91320 (together with its Affiliates, “Immunex”), Wyeth (formerly, “American Home Products Corporation”), a Delaware corporation having its corporate headquarters at Five Giralda Farms, Madison, New Jersey 07940, acting through its Wyeth Pharmaceuticals division (together with its Affiliates, “Wyeth”), and Boehringer Ingelheim Pharma KG, a German corporation having a place of business at Birkendorfer Straße 65, 88397 Biberach an der Riss, Federal Republic of Germany (“BIP”), and amends the Enbrel® Supply Agreement effective as of November 5, 1998, as amended by Amendment No. 1 effective June 27, 2000 and Amendment No. 2 effective June 3, 2002 (the “Agreement”).
RESTRICTED STOCK PURCHASE AGREEMENTRestricted Stock Purchase Agreement • March 10th, 2003 • Amgen Inc • Biological products, (no disgnostic substances)
On this 14th day of January, 2002, Amgen Inc., a Delaware corporation (the “Company”), pursuant to its Amended and Restated 1991 Equity Incentive Plan (the “Plan”) has granted to you, the grantee named above, a right to purchase Twenty-Seven Thousand Five Hundred (27,500) shares (the “Shares”) of the $.0001 par value common stock of the Company (“Common Stock”) pursuant to the terms of this Restricted Stock Purchase Agreement (this “Agreement”) and the Plan. Capitalized terms not defined herein shall have the meanings assigned to such terms in the Plan.
